S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Cellebrite DI Stock Forecast, Price & News

+0.19 (+2.24%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
231,995 shs
Average Volume
437,195 shs
Market Capitalization
$1.62 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CLBT News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

Cellebrite DI logo

About Cellebrite DI

TWC Tech Holdings II Corp. is a blank check company. It aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase and reorganization. TWC Tech Holdings II Corp. is based in San Francisco, California.


Cellebrite DI (NASDAQ:CLBT) Hits New 12-Month Low at $8.62
November 23, 2021 |  americanbankingnews.com
Cellebrite DI (NASDAQ:CLBT) Shares Gap Up to $9.56
November 12, 2021 |  americanbankingnews.com
Cellebrite DI (NASDAQ:CLBT) Shares Down 7%
November 11, 2021 |  americanbankingnews.com
Cellebrite Announces Third Quarter 2021 Results
November 10, 2021 |  finance.yahoo.com
Cellebrite DI (CLBT) Set to Announce Earnings on Wednesday
November 3, 2021 |  americanbankingnews.com
Cellebrite To Acquire Digital Clues For Undisclosed Terms
October 11, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Holding & other investment offices
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
Book Value
($0.69) per share


Pretax Margin




Free Float
Market Cap
$1.62 billion

Company Calendar

Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.08 out of 5 stars

Business Services Sector

137th out of 420 stocks

Holding & Other Investment Offices Industry

11th out of 519 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Cellebrite DI (NASDAQ:CLBT) Frequently Asked Questions

Is Cellebrite DI a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cellebrite DI in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cellebrite DI stock.
View analyst ratings for Cellebrite DI
or view top-rated stocks.

When is Cellebrite DI's next earnings date?

Cellebrite DI is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Cellebrite DI

What guidance has Cellebrite DI issued on next quarter's earnings?

Cellebrite DI issued an update on its FY 2021 earnings guidance on Wednesday, November, 24th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $241.50 million-$243.50 million, compared to the consensus revenue estimate of $234.42 million.

What price target have analysts set for CLBT?

4 analysts have issued 1-year price objectives for Cellebrite DI's shares. Their forecasts range from $12.00 to $20.00. On average, they expect Cellebrite DI's share price to reach $15.67 in the next twelve months. This suggests a possible upside of 80.5% from the stock's current price.
View analysts' price targets for Cellebrite DI
or view top-rated stocks among Wall Street analysts.

What is Cellebrite DI's stock symbol?

Cellebrite DI trades on the NASDAQ under the ticker symbol "CLBT."

Who are Cellebrite DI's major shareholders?

Cellebrite DI's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Park West Asset Management LLC (1.47%), CIBC Asset Management Inc (1.17%), Migdal Insurance & Financial Holdings Ltd. (0.75%), Crescent Park Management L.P. (0.59%), Geode Capital Management LLC (0.04%) and PEAK6 Investments LLC (0.00%).

Which major investors are buying Cellebrite DI stock?

CLBT stock was purchased by a variety of institutional investors in the last quarter, including Park West Asset Management LLC, CIBC Asset Management Inc, Migdal Insurance & Financial Holdings Ltd., Crescent Park Management L.P., Geode Capital Management LLC, PEAK6 Investments LLC, Mawer Investment Management Ltd., and Citadel Advisors LLC.

How do I buy shares of Cellebrite DI?

Shares of CLBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cellebrite DI's stock price today?

One share of CLBT stock can currently be purchased for approximately $8.68.

How much money does Cellebrite DI make?

Cellebrite DI has a market capitalization of $1.62 billion.

How many employees does Cellebrite DI have?

Cellebrite DI employs 2 workers across the globe.

Where are Cellebrite DI's headquarters?

How can I contact Cellebrite DI?

Cellebrite DI's mailing address is Four Embarcadero Center Suite 2100, SAN FRANCISCO CA, 94111. The company can be reached via phone at 415-780-9981.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.